These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28605082)

  • 1. Toxoplasmosis in hematopoietic cell transplant recipients.
    Gajurel K; Dhakal R; Montoya JG
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28605082
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of toxoplasmosis in transplant recipients: an update.
    Dard C; Marty P; Brenier-Pinchart MP; Garnaud C; Fricker-Hidalgo H; Pelloux H; Pomares C
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):447-460. PubMed ID: 29855213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.
    Robert-Gangneux F; Meroni V; Dupont D; Botterel F; Garcia JMA; Brenier-Pinchart MP; Accoceberry I; Akan H; Abbate I; Boggian K; Bruschi F; Carratalà J; David M; Drgona L; Djurković-Djaković O; Farinas MC; Genco F; Gkrania-Klotsas E; Groll AH; Guy E; Hirzel C; Khanna N; Kurt Ö; Junie LM; Lazzarotto T; Len O; Mueller NJ; Munoz P; Pana ZD; Roilides E; Stajner T; van Delden C; Villena I; Pelloux H; Manuel O
    Emerg Infect Dis; 2018 Aug; 24(8):1497-1504. PubMed ID: 30014843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.
    Adekunle RO; Sherman A; Spicer JO; Messina JA; Steinbrink JM; Sexton ME; Lyon GM; Mehta AK; Phadke VK; Woodworth MH
    Transpl Infect Dis; 2021 Aug; 23(4):e13636. PubMed ID: 33993599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma in crush preparation of the brain biopsy from a cord blood hematopoietic stem cell transplant recipient.
    Borys E; Alexander Jones G; Pambuccian SE
    Diagn Cytopathol; 2018 Dec; 46(12):1073-1076. PubMed ID: 30353681
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations.
    Gajurel K; Dhakal R; Montoya JG
    Curr Opin Infect Dis; 2015 Aug; 28(4):283-92. PubMed ID: 26098500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients.
    Hakko E; Ozkan HA; Karaman K; Gulbas Z
    Transpl Infect Dis; 2013 Dec; 15(6):575-80. PubMed ID: 24103000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasmosis as an Early Complication of Allogeneic Hematopoietic Cell Transplantation.
    Robin C; Leclerc M; Angebault C; Redjoul R; Beckerich F; Cabanne L; Foulet F; Pautas C; Toma A; Maury S; Botterel F; Cordonnier C
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2510-2513. PubMed ID: 31381996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient.
    Osthoff M; Chew E; Bajel A; Kelsey G; Panek-Hudson Y; Mason K; Szer J; Ritchie D; Slavin M
    Transpl Infect Dis; 2013 Feb; 15(1):E14-9. PubMed ID: 23279790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining Toxoplasma high-risk autologous and allogeneic hematopoietic stem cell transplantation patients by systematic pre-transplant PCR screening of stem cell originated buffy coat.
    Caner A; Dönmez A; Döşkaya M; Değirmenci A; Tombuloğlu M; Cağirgan S; Guy E; Francis J; Soyer NA; Gürüz Y
    Parasitol Int; 2012 Dec; 61(4):565-71. PubMed ID: 22609887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective study of the implementation of the qualitative PCR technique in biological samples for monitoring toxoplasmosis in pediatric patients receiving hematopoietic stem cell transplantation].
    Nigro MG; Figueroa C; Ledesma BA
    Rev Argent Microbiol; 2014; 46(1):24-9. PubMed ID: 24721270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.
    Chueng TA; Moroz IV; Anderson AD; Morris MI; Komanduri KV; Camargo JF
    Transpl Infect Dis; 2020 Feb; 22(1):e13198. PubMed ID: 31614058
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.
    Isa F; Saito K; Huang YT; Schuetz A; Babady NE; Salvatore S; Pessin M; van Besien K; Perales MA; Giralt S; Sepkowitz K; Papanicolaou GA; Soave R; Kamboj M
    Clin Infect Dis; 2016 Aug; 63(4):565-8. PubMed ID: 27199460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral toxoplasmosis in an adolescent post allogeneic hematopoietic stem cell transplantation: successful outcome by antiprotozoal chemotherapy and CD4+ T-lymphocyte recovery.
    Kerl K; Ehlert K; Brentrup A; Schiborr M; Keyvani K; Becker K; Rossig C; Groll AH
    Transpl Infect Dis; 2015 Feb; 17(1):119-24. PubMed ID: 25581774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
    Edvinsson B; Lundquist J; Ljungman P; Ringdén O; Evengård B
    APMIS; 2008 May; 116(5):345-51. PubMed ID: 18452424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.
    Conrad A; Le Maréchal M; Dupont D; Ducastelle-Leprêtre S; Balsat M; Labussière-Wallet H; Barraco F; Nicolini FE; Thomas X; Gilis L; Chidiac C; Ferry T; Wallet F; Rabodonirina M; Salles G; Michallet M; Ader F;
    Clin Microbiol Infect; 2016 Jul; 22(7):636-41. PubMed ID: 27172809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
    Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
    Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasmosis Among 38 751 Hematopoietic Stem-cell Transplant Recipients: A Systematic Review of Disease Prevalence and a Compilation of Imaging and Autopsy Findings.
    Contopoulos-Ioannidis DG; Cho SM; Bertaina A; Leung AN; Fischbein N; Lanzman B; Schwenk HT; Montoya JG
    Transplantation; 2021 Dec; 105(12):e375-e386. PubMed ID: 33654004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasmosis after hematopoietic stem cell transplantation.
    Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C
    Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and computed tomography findings of pulmonary toxoplasmosis after hematopoietic stem cell transplantation.
    Sumi M; Norose K; Hikosaka K; Kaiume H; Takeda W; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Kuraishi H; Watanabe M; Kobayashi H
    Int J Hematol; 2016 Dec; 104(6):729-740. PubMed ID: 27531150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.